ethyl 5-(2,5-dimethylphenoxy)pentanoate | 443924-70-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: ethyl 5-(2,5-dimethylphenoxy)pentanoate
• 英文别名: Ethyl 5-(2,5-dimethylphenoxy)pentanoate
• CAS: 443924-70-7
• 化学式: C₁₅H₂₂O₃
• 分子量: 250.338
• InChiKey: DCTNVHXRPUVFTO-UHFFFAOYSA-N

物化性质

• 沸点：
  344.3±30.0 °C(Predicted)
• 密度：
  1.007±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  18
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl 5-(2,5-dimethylphenoxy)pentanoate 在 氢氧化钾 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 六甲基磷酰三胺 、 乙醇 为溶剂， 生成 5-(2,5-dimethylphenoxy)-2-methylpentanoic acid
  参考文献：
  名称：

  Synthesis and antiplatelet activity of gemfibrozil chiral analogues

  摘要：

  The chiral analogues of gemfibrozil 5-(2.5-dimethylphenoxy)-2-methylpentanoic acid and 5-(2,5-dimethylphenoxy)-2-ethylpentanoic acid were synthesized in optically active form using (S)-4-(1-methylethyl)-2-oxazolidinone as chiral auxiliary. All compounds inhibit human platelet aggregation. from these data. one can surmise that all tested compounds and gemfibrozil act at the platelet level with different mechanism than that of ASA, even if with a different potency. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00021-5
• 作为产物：
  描述：

  2,5-二甲基苯酚 、 5-溴戊酸乙酯 在 potassium carbonate 、 四丁基溴化铵 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.5h， 生成 ethyl 5-(2,5-dimethylphenoxy)pentanoate
  参考文献：
  名称：

  作为法尼醇X受体（FXR）拮抗剂的新型SIPI-7623衍生物的合成和生物学评估。

  摘要：

  大多数报道的甾体FXR拮抗剂由于药效低而受到限制。我们描述了作为FXR拮抗剂的新型非甾体支架SIPI-7623衍生物的设计和合成。 与SIPI-7623（IC 50  = 40.8±1.7μM）和古古甾酮（IC 50  = 45.9± 1.1μM）相比，最有效的化合物A-11（IC 50 = 7.8± 1.1μM）表现出更好的活性。还研究了A-11在FXR的配体结合域中的对接。

  DOI：

  10.1007/s11030-018-9843-2

文献信息

• Synthesis and biological evaluation of novel SIPI-7623 derivatives as farnesoid X receptor (FXR) antagonists
  作者：Si-Yun Nian、Guo-Ping Wang、Zheng-Li Jiang、Ying Xiao、Mo-Han Huang、Yi-Huan Zhou、Xiang-Duan Tan

  DOI：10.1007/s11030-018-9843-2

  日期：2019.2

  Most of reported steroidal FXR antagonists are restricted due to low potency. We described the design and synthesis of novel nonsteroidal scaffold SIPI-7623 derivatives as FXR antagonists. The most potent compound A-11 (IC50 = 7.8 ± 1.1 μM) showed better activity compared to SIPI-7623 (IC50 = 40.8 ± 1.7 μM) and guggulsterone (IC50 = 45.9 ± 1.1 μM). Docking of A-11 in FXR’s ligand-binding domain was

  大多数报道的甾体FXR拮抗剂由于药效低而受到限制。我们描述了作为FXR拮抗剂的新型非甾体支架SIPI-7623衍生物的设计和合成。 与SIPI-7623（IC 50  = 40.8±1.7μM）和古古甾酮（IC 50  = 45.9± 1.1μM）相比，最有效的化合物A-11（IC 50 = 7.8± 1.1μM）表现出更好的活性。还研究了A-11在FXR的配体结合域中的对接。
• Synthesis and antiplatelet activity of gemfibrozil chiral analogues
  作者：Alessandra Ammazzalorso、Rosa Amoroso、Mario Baraldi、Giancarlo Bettoni、Daniela Braghiroli、Barbara De Filippis、Andrea Duranti、Marco Moretti、Paolo Tortorella、Maria Luisa Tricca、Francesca Vezzalini

  DOI：10.1016/s0960-894x(02)00021-5

  日期：2002.3

  The chiral analogues of gemfibrozil 5-(2.5-dimethylphenoxy)-2-methylpentanoic acid and 5-(2,5-dimethylphenoxy)-2-ethylpentanoic acid were synthesized in optically active form using (S)-4-(1-methylethyl)-2-oxazolidinone as chiral auxiliary. All compounds inhibit human platelet aggregation. from these data. one can surmise that all tested compounds and gemfibrozil act at the platelet level with different mechanism than that of ASA, even if with a different potency. (C) 2002 Elsevier Science Ltd. All rights reserved.